Form 4: MYRIAD GENETICS COO Sells Shares for Tax Obligations

Myriad Genetics' Chief Operating Officer, Mark Verratti, disposed of 2,055 shares of common stock to cover tax withholding obligations related to vested restricted stock units.

Summary

• Mark Verratti, Chief Operating Officer of MYRIAD GENETICS INC (MYGN), reported a transaction on March 22, 2026.
• The transaction involved the disposition of 2,055 shares of Common Stock.
• These shares were withheld by the Issuer to satisfy tax withholding obligations in connection with the vesting of previously granted restricted stock units.
• The shares were disposed of at a price of $4.58 per share.
• Following this transaction, Mark Verratti beneficially owns 630,715 shares of Common Stock directly.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, as it represents a routine, non-discretionary disposition of shares to cover tax liabilities associated with vested restricted stock units, which is common for executives receiving equity compensation.

Future Outlook

This filing does not contain any forward-looking statements or guidance.

Industry Context

StockSavvy.ai notes that insider transactions, particularly those related to tax withholding on vested equity awards, are common occurrences across all industries and typically do not reflect a change in management's outlook on the company's performance.

Stakeholder Impact

• Shareholders: Minimal impact, as this is a routine, non-discretionary transaction for tax purposes and does not indicate a change in the insider's investment thesis or company fundamentals.

Key Dates

Keywords

MYRIAD GENETICS, MYGN, Form 4, Insider Transaction, Stock Sale, Tax Withholding, Restricted Stock Units, Officer, Mark Verratti